"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,ES,T3,ES 2360519 T3,195-815-927-934-984,2011-06-06,2011,ES 06739100 T,2006-03-20,US 67428005 P,2005-04-22,CONJUGADO DE CIANINA-CLOROTOXINA Y PROCEDIMIENTO PARA LA VISUALIZACION INTRAQUIRURGICA DEL CANCER.,"A chlorotoxin conjugate detectable by fluorescence imaging that allows for intra-operative visualization of cancerous tissues, compositions that include the chlorotoxin conjugate, and methods for using the chlorotoxin conjugate.",UNIV WASHINGTON;;FRED HUTCHINSON CANCER RES FOUNDATION;;HUTCHINSON FRED CANCER RES,VEISEH MANDANA;;BAHRAMI S-BAHRAM;;OLSON JAMES;;GABIKIAN PATRIK;;ELLENBOGEN RICHARD;;SZE RAYMOND;;VEISEH OMID;;ZHANG MIQIN,,https://lens.org/195-815-927-934-984,Granted Patent,no,0,0,11,11,0,A61K49/0041;;A61K49/0056;;A61K47/6415;;A61K38/16;;A61K49/0032;;C07K14/43522;;A61P35/00;;A61K49/0056;;A61K49/0041;;A61K47/6415;;A61K49/0032;;C07K14/43522;;A61K38/16;;A61K49/0017;;A61K49/005;;A61K51/08;;A61B17/22;;G01N33/57492,C07K14/435;;A61P35/00,,0,0,,,,ACTIVE
2,DE,D1,DE 602006020710 D1,164-273-191-553-733,2011-04-28,2011,DE 602006020710 T,2006-03-20,US 67428005 P;;US 2006/0010170 W,2005-04-22,FLUORESZENTES CHLOROTOXINKONJUGAT UND VERFAHREN ZUR INTRAOPERATIVEN SICHTBARMACHUNG VON KREBS,"A chlorotoxin conjugate detectable by fluorescence imaging that allows for intra-operative visualization of cancerous tissues, compositions that include the chlorotoxin conjugate, and methods for using the chlorotoxin conjugate.",FRED HUTCHINSON CANCER RES FOUNDATION;;UNIV WASHINGTON,VEISEH MANDANA;;BAHRAMI S-BAHRAM;;OLSON JAMES;;GABIKIAN PATRIK;;ELLENBOGEN RICHARD;;SZE RAYMOND;;VEISEH OMID;;ZHANG MIQIN,,https://lens.org/164-273-191-553-733,Granted Patent,no,0,0,11,11,0,A61K49/0041;;A61K49/0056;;A61K47/6415;;A61K38/16;;A61K49/0032;;C07K14/43522;;A61P35/00;;A61K49/0056;;A61K49/0041;;A61K47/6415;;A61K49/0032;;C07K14/43522;;A61K38/16;;A61K49/0017;;A61K49/005;;A61K51/08;;A61B17/22;;G01N33/57492,C07K14/435;;A61P35/00,,0,0,,,,ACTIVE
3,EP,A2,EP 1877428 A2,084-795-984-927-932,2008-01-16,2008,EP 06739100 A,2006-03-20,US 2006/0010170 W;;US 67428005 P,2005-04-22,CYANINE- CHLOROTOXIN CONJUGATE AND METHOD FOR INTRA-OPERATIVE VISUALIZATION OF CANCER,"A chlorotoxin conjugate detectable by fluorescence imaging that allows for intra-operative visualization of cancerous tissues, compositions that include the chlorotoxin conjugate, and methods for using the chlorotoxin conjugate.",UNIV WASHINGTON;;FRED HUTCHINSON CANCER RES FOU,VEISEH MANDANA;;BAHRAMI S-BAHRAM;;OLSON JAMES;;GABIKIAN PATRIK;;ELLENBOGEN RICHARD;;SZE RAYMOND;;VEISEH OMID;;ZHANG MIQIN,"FRED HUTCHINSON CANCER RESEARCH CENTER, US (2011-09-05);;FRED HUTCHINSON CANCER CENTER; US (2022-09-16);;UNIVERSITY OF WASHINGTON, SEATTLE, US (2023-02-10);;UNIVERSITY OF WASHINGTON, US (2022-11-22);;UNIVERSITY OF WASHINGTON (2011-04-13);;FRED HUTCHINSON CANCER RESEARCH CENTER (2011-06-30);;FRED HUTCHINSON CANCER RESEARCH CENTER, 98109-, US (2011-09-05);;UNIVERSITY OF WASHINGTON; US (2022-09-13);;FRED HUTCHINSON CANCER CENTER, SEATTLE, US (2023-02-10);;FRED HUTCHINSON CANCER CENTER (2023-01-25);;FRED HUTCHINSON CANCER CENTER, US (2022-11-22)",https://lens.org/084-795-984-927-932,Patent Application,yes,0,0,11,11,0,A61K49/0041;;A61K49/0056;;A61K47/6415;;A61K38/16;;A61K49/0032;;C07K14/43522;;A61P35/00;;A61K49/0056;;A61K49/0041;;A61K47/6415;;A61K49/0032;;C07K14/43522;;A61K38/16;;A61K49/0017;;A61K49/005;;A61K51/08;;A61B17/22;;G01N33/57492,C07K14/435;;A61P35/00,,0,0,,,,ACTIVE
4,EP,B1,EP 1877428 B1,035-772-818-576-533,2011-03-16,2011,EP 06739100 A,2006-03-20,US 2006/0010170 W;;US 67428005 P,2005-04-22,CYANINE- CHLOROTOXIN CONJUGATE AND METHOD FOR INTRA-OPERATIVE VISUALIZATION OF CANCER,"A chlorotoxin conjugate detectable by fluorescence imaging that allows for intra-operative visualization of cancerous tissues, compositions that include the chlorotoxin conjugate, and methods for using the chlorotoxin conjugate.",UNIV WASHINGTON;;FRED HUTCHINSON CANCER RES FOUNDATION,VEISEH MANDANA;;BAHRAMI S-BAHRAM;;OLSON JAMES;;GABIKIAN PATRIK;;ELLENBOGEN RICHARD;;SZE RAYMOND;;VEISEH OMID;;ZHANG MIQIN,"FRED HUTCHINSON CANCER RESEARCH CENTER, US (2011-09-05);;FRED HUTCHINSON CANCER CENTER; US (2022-09-16);;UNIVERSITY OF WASHINGTON, SEATTLE, US (2023-02-10);;UNIVERSITY OF WASHINGTON, US (2022-11-22);;UNIVERSITY OF WASHINGTON (2011-04-13);;FRED HUTCHINSON CANCER RESEARCH CENTER (2011-06-30);;FRED HUTCHINSON CANCER RESEARCH CENTER, 98109-, US (2011-09-05);;UNIVERSITY OF WASHINGTON; US (2022-09-13);;FRED HUTCHINSON CANCER CENTER, SEATTLE, US (2023-02-10);;FRED HUTCHINSON CANCER CENTER (2023-01-25);;FRED HUTCHINSON CANCER CENTER, US (2022-11-22)",https://lens.org/035-772-818-576-533,Granted Patent,yes,0,0,11,11,0,A61K49/0041;;A61K49/0056;;A61K47/6415;;A61K38/16;;A61K49/0032;;C07K14/43522;;A61P35/00;;A61K49/0056;;A61K49/0041;;A61K47/6415;;A61K49/0032;;C07K14/43522;;A61K38/16;;A61K49/0017;;A61K49/005;;A61K51/08;;A61B17/22;;G01N33/57492,C07K14/435;;A61P35/00,,3,2,016-065-057-100-394;;028-723-617-551-773,10.1602/neurorx.2.1.44;;10.1007/bf03206641;;pmc539319;;15717056;;14871599;;10.1016/s0301-4622(03)00218-7,"Annual Report 2004 by the ""Joint Institute for Nanoscience"", Eds. D. B. Baer, C. T. Campbell, November 2005. ""Smart Superparamagnetic Imaging Probes for Brain Tumor Research"", J. Gunn.;;EGLETON R. D., DAVIS T. P.: ""Development of Neuropeptide Drugs that Cross the Blood-Brain Barrier"", J AM SOC EXP NEUROTHERAPEUTICS, vol. 2, January 2005 (2005-01-01), pages 44 - 53, XP025343798;;TATIKOLOV A S; COSTA S M B: ""Complexation of polymethine dyes with human serum albumin: a spectroscopic study"", BIOPHYSICAL CHEMISTRY, vol. 107, 1 January 2004 (2004-01-01), pages 33 - 49, XP002381135",ACTIVE
5,AT,T1,AT E502048 T1,117-546-881-264-951,2011-04-15,2011,AT 06739100 T,2006-03-20,US 67428005 P;;US 2006/0010170 W,2005-04-22,FLUORESZENTES CHLOROTOXINKONJUGAT UND VERFAHREN ZUR INTRAOPERATIVEN SICHTBARMACHUNG VON KREBS,"A chlorotoxin conjugate detectable by fluorescence imaging that allows for intra-operative visualization of cancerous tissues, compositions that include the chlorotoxin conjugate, and methods for using the chlorotoxin conjugate.",UNIV WASHINGTON;;FRED HUTCHINSON CANCER RES FOUNDATION,VEISEH MANDANA;;BAHRAMI S-BAHRAM;;OLSON JAMES;;GABIKIAN PATRIK;;ELLENBOGEN RICHARD;;SZE RAYMOND;;VEISEH OMID;;ZHANG MIQIN,,https://lens.org/117-546-881-264-951,Granted Patent,no,0,0,11,11,0,A61K49/0041;;A61K49/0056;;A61K47/6415;;A61K38/16;;A61K49/0032;;C07K14/43522;;A61P35/00;;A61K49/0056;;A61K49/0041;;A61K47/6415;;A61K49/0032;;C07K14/43522;;A61K38/16;;A61K49/0017;;A61K49/005;;A61K51/08;;A61B17/22;;G01N33/57492,,,0,0,,,,ACTIVE
6,US,A1,US 2014/0241993 A1,066-498-645-687-862,2014-08-28,2014,US 201414273374 A,2014-05-08,US 201414273374 A;;US 89772107 A;;US 2006/0010170 W;;US 67428005 P,2005-04-22,FLUORESCENT CHLOROTOXIN CONJUGATE AND METHOD FOR INTRA-OPERATIVE VISUALIZATION OF CANCER,"A chlorotoxin conjugate detectable by fluorescence imaging that allows for intra-operative visualization of cancerous tissues, compositions that include the chlorotoxin conjugate, and methods for using the chlorotoxin conjugate.",UNIV WASHINGTON;;HUTCHINSON FRED CANCER RES,ZHANG MIQIN;;ELLENBOGEN RICHARD G;;SZE RAYMOND W;;VEISEH OMID;;OLSON JAMES;;VEISHE MANDANA;;GABIKIAN PATRIK;;BAHRAMI S-BAHRAM,,https://lens.org/066-498-645-687-862,Patent Application,yes,4,9,11,11,0,A61K49/0041;;A61K49/0056;;A61K47/6415;;A61K38/16;;A61K49/0032;;C07K14/43522;;A61P35/00;;A61K49/0056;;A61K49/0041;;A61K47/6415;;A61K49/0032;;C07K14/43522;;A61K38/16;;A61K49/0017;;A61K49/005;;A61K51/08;;A61B17/22;;G01N33/57492,A61B17/22;;C07K14/435;;A61K49/00;;G01N33/574,424/9.6;;530/300;;435/7.23;;514/1.2;;435/375;;606/110,2,2,013-199-652-970-567;;013-199-652-970-567,17335414;;10.1517/17425247.4.2.175;;17335414;;10.1517/17425247.4.2.175,"Mamelak et al (Expert Opin. Drug Deliv., 2007, Vol. 4, No. 2, pages 175-186.;;Mamelak et al (Expert Opin. Drug Deliv., 2007, Vol. 4, No. 2, pages 175-186.",DISCONTINUED
7,US,B2,US 8778310 B2,083-960-166-398-880,2014-07-15,2014,US 89772107 A,2007-08-31,US 89772107 A;;US 2006/0010170 W;;US 67428005 P,2005-04-22,Fluorescent chlorotoxin conjugate and method for intra-operative visualization of cancer,"A chlorotoxin conjugate detectable by fluorescence imaging that allows for intra-operative visualization of cancerous tissues, compositions that include the chlorotoxin conjugate, and methods for using the chlorotoxin conjugate.",ZHANG MIQIN;;ELLENBOGEN RICHARD G;;SZE RAYMOND W;;VEISEH OMID;;OLSON JAMES M;;VEISEH MANDANA;;GABIKIAN PATRIK;;BAHRAMI S-BAHRAM;;UNIV WASHINGTON;;HUTCHINSON FRED CANCER RES,ZHANG MIQIN;;ELLENBOGEN RICHARD G;;SZE RAYMOND W;;VEISEH OMID;;OLSON JAMES M;;VEISEH MANDANA;;GABIKIAN PATRIK;;BAHRAMI S-BAHRAM,FRED HUTCHINSON CANCER RESEARCH CENTER (2008-01-22);;WASHINGTON UNIVERSITY OF (2008-04-14);;FRED HUTCHINSON CANCER CENTER (2022-03-30),https://lens.org/083-960-166-398-880,Granted Patent,yes,74,10,11,11,0,A61K49/0041;;A61K49/0056;;A61K47/6415;;A61K38/16;;A61K49/0032;;C07K14/43522;;A61P35/00;;A61K49/0056;;A61K49/0041;;A61K47/6415;;A61K49/0032;;C07K14/43522;;A61K38/16;;A61K49/0017;;A61K49/005;;A61K51/08;;A61B17/22;;G01N33/57492,A61B5/00;;A61B8/00;;A61B10/00;;A61K38/16;;A61K49/00;;A61K51/08,424/9.6;;424/1.11;;424/1.65;;424/1.69,31,24,054-821-923-634-288;;009-498-083-230-272;;019-024-497-415-689;;011-306-165-996-389;;019-655-508-001-985;;003-464-398-363-332;;149-905-841-995-437;;014-264-683-268-986;;054-821-923-634-288;;005-826-885-809-029;;108-740-247-130-967;;059-164-173-990-121;;014-509-440-888-585;;016-065-057-100-394;;141-110-824-694-86X;;024-161-451-885-265;;022-153-512-298-505;;014-411-541-182-455;;028-723-617-551-773;;043-888-457-701-427;;070-631-400-706-871;;047-365-285-601-835;;021-837-168-406-052;;134-006-521-216-920,10.1021/nl0502569;;15943433;;14623938;;10.1177/002215540305101214;;10.1016/s0927-7757(00)00633-6;;15078992;;10.1158/1535-7163.481.3.4;;10.1074/jbc.m205662200;;12454020;;10.1021/ja049195r;;15186157;;9809993;;10.1021/ja026501x;;12105897;;10.1021/nl0502569;;15943433;;10.1038/nm0103-123;;12514725;;11922461;;10.1016/s0142-9612(01)00267-8;;15601762;;10.1073/pnas.0408191101;;pmc539314;;21210710;;pmc3086956;;10.1021/jm101018r;;10.1602/neurorx.2.1.44;;10.1007/bf03206641;;pmc539319;;15717056;;15809479;;10.1016/j.jchromb.2003.11.029;;15025999;;20209054;;pmc2832013;;10.1371/annotation/fe02e23b-5168-4586-ba49-d0e0286f4ad3;;10.1371/journal.pone.0009536;;10.1093/jnci/88.18.1308;;8797771;;14871599;;10.1016/s0301-4622(03)00218-7;;9891977;;10.1016/s0014-5793(98)01589-0;;19638572;;10.1158/0008-5472.can-09-1157;;pmc2742601;;17638899;;10.1158/0008-5472.can-06-3948;;8589602;;10.1007/bf00211777;;10.1002/(sici)1098-2299(199707/08)41:3/4<142::aid-ddr5>3.0.co;2-l,"Veiseh et al (Nano Letters, Apr. 30, 2005, vol. 5, No. 6, pp. 1003-1008).;;Berlier, J.E., et al., ""Quantitative Comparison of Long-Wavelength Alexa Fluor Dyes to Cy Dyes: Fluorescence of the Dyes and Their Bioconjugates,"" The Journal of Histochemistry & Cytochemistry 51(12):1699-1712, 2003.;;Butterworth, M.D., et al., ""Preparation of Ultrafine Silica- and PEG-Coated Magnetite Particles,"" Colloids and Surfaces A: Physicochemistry Engineering Aspects 179:93 102, 2001.;;Citrin, D., et al., ""In Vivo Tumor Imaging in Mice With Near-Infrared Labeled Endostatin,"" Molecular Cancer Therapeutics 3(4):481-488, 2004.;;Deshane, J., et al., ""Chlorotoxin Inhibits Glioma Cell Invasion Via Matrix Metalloproteinase-2,"" The Journal of Biological Chemistry 278(6):4135-4144, Feb. 7, 2003.;;Kohler, N., et al., ""A Bifunctional Poly(Ethylene Glycol) Silane Immobilized on Metallic Oxide Based Nanoparticles for Conjugation With Cell Targeting Agents,"" Journal of the American Chemical Society 126(23):7206 7211, 2004.;;Soroceanu, L., et al., ""Use of Chlorotoxin for Targeting of Primary Brain Tumors,"" Cancer Research 58:4871-4879, Nov. 1, 1998.;;Sun, S., and H. Zeng, ""Size Controlled Synthesis of Magnetite Nanoparticles,"" Journal of the American Chemical Society 124(28):8204 8205, 2002.;;Veiseh, O., et al., ""Optical and MRI Multifunctional Nanoprobe for Targeting Gliomas,"" Nano Letters 5(6):1003-1008, 2005.;;Weissleder, R., and V. Ntziachristos, ""Shedding Light Onto Live Molecular Targets,"" Nature Medicine 9 (1):123-128, Jan. 2003.;;Zhang, Y., et al., ""Surface Modification of Superparamagnetic Magnetite Nanoparticles and Their Intracellular Uptake,"" Biomaterials 23:1553 1561, 2002.;;Gunn, J., et al., ""Smart Superparamagnetic Imaging Probes for Brain Tumor Research,"" in D.B. Baer and C.T. Campbell (eds.), Joint Institute for Nanoscience Annual Report, 2004, Nov. 2005, pp. 3.65-3.66.;;Jiang, T., et al., ""Tumor Imaging by Means of Proteolytic Activation of Cell-Penetrating Peptides,"" Proceedings of the National Academy of Sciences USA (PNAS) 101(51):17867-17872, Dec. 2004.;;Invitation Pursuant to Article 94(3) and Rule 71(1) EPC, mailed Mar. 1, 2010, in corresponding European Application No. 06 739 100.3, filed Mar. 20, 2006, 3 pages.;;Akcan, et al. Chemical re-engineering of chlorotoxin improves bioconjugation properties for tumor imaging and targeted therapy. J Med Chem. Feb. 10, 2011;54(3):782-7. doi: 10.1021/jm101018r. Epub Jan. 6, 2011;;Egleton, R.D. and Davis, T.P., Development of Neuropeptide Drugs that Cross the Blood-Brain Barrier, J. Am. Soc. Exp. NeuroTherapeutics 2:44-53 (2005).;;European search report and search opinion dated Oct. 15, 2013 for EP Application No. 11780950.9.;;Hockaday, D.C. et al., Imaging Glioma Extent with 131I-TM-601, J. Nuc. Med. 46(4): 580-586 (2005).;;Huys, et al. Structure-function study of a chlorotoxin-chimer and its activity on Kv1.3 channels. J Chromatogr B Analyt Technol Biomed Life Sci. Apr. 15, 2004; 803(1):67-73.;;International search report and written opinion dated Oct. 6, 2010 for PCT/US2006/010170.;;International search report and written opinion dated Nov. 18, 2011 for PCT/US2011/023797.;;Lee, M. J., et al., Rapid Pharmacokinetic and Biodistribution Studies Using Cholorotoxin-conjugated Iron oxide Nanoparticles: A Novel Non-Radioactive Method, PLoS One 5(3):e9536 1-8 (2010).;;Milross, et al. Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel. J Natl Cancer Inst. Sep. 18, 1996; 88(18):1308-14.;;Tatikolov, A.S. And Costa, S.M.B., Complexation of polymethine dyes with human serum albumin: a spectroscopic study, Biophys. Chem. 107:33-49 (2004).;;Tytgat, et al. Purification and partial characterization of a 'short' insectotoxin-like peptide from the venom of the scorpion Parabuthus schlechteri. FEBS Lett. Dec. 28, 1998; 441(3):387-91.;;Veiseh, et al. Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier. Cancer Res. Aug. 1, 2009; 69(15):6200-7. doi: 10.1158/0008-5472.CAN-09-1157. Epub Jul. 28, 2009.;;Veiseh, et al. Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci. Cancer Res. Jul. 15, 2007; 67(14):6882-8.;;Wishart, et al. 1H, 13C and 15N chemical shift referencing in biomolecular NMR. J.Biomol NMR. Sep. 1995; 6(2):135-40.;;International search report and written opinion dated Apr. 8, 2014 for PCT/US2013/074215.;;International search report and written opinion dated Apr. 22, 2014 for PCT/US2013/074218.;;Shiue. Identification of candidate genes for drug discovery by differential display Drug Development Research. New York. 1997; 41:142-159.",ACTIVE
